Small molecule hit and lead compounds for most indications.

An international chemistry contract research organisation has built an extensive skillset in synthetic and medicinal chemistry. They are looking for new hit and lead compounds that they could advance into a robust clinical candidate, with desired properties agreed upon. They would share in the eventual commercial return but not the IP. There is little limit in terms of indication areas.

Type of partner sought: industry and academia; type of activity of the partner: drug discovery and optimisation; task to be performed by the partner sought: to provide non-confidential information on high priority projects and the type of collaboration envisaged. Mostly, joint ventures and technical cooperation are sought around early stage small compounds. First, desired technical and commercial goals will be set followed by a detailed description of the involvement of either party.

Per maggiori informazioni clicca qui.

Sei interessato al profilo? Scrivi a